SEC Form D · Amendment · filed April 22, 2019
Noveome Biotherapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Robert Langer · Pittsburgh, PADirectorJohn Mcarthur · Pittsburgh, PADirectorPatrick Welch · Pittsburgh, PADirectorWilliam Golden · Pittsburgh, PAExec · DirectorTerence Golden · Pittsburgh, PADirectorDonald Wagner · Pittsburgh, PADirectorAndrew J. Spokes · San Francisco, CADirectorBruce C. Sanders · Atlanta, GADirectorMatthew Buck · Hong Kong, Hong KongDirectorSteven Shores · Atlanta, GADirectorCharles Mann · Fort Wayne, INExec · DirectorChristopher T. Pierson · Lake Mary, FLDirectorMichael Huber · New York, NYDirectorLeland K. Carter · Bethlehem, PADirectorKeith K. Caldwell · Bethlehem, PADirectorRichard K. Thompson · Bethlehem, PAExec · DirectorJeffrey D. Martin · Bethlehem, PADirectorBradley Fishman · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗